Results 221 to 230 of about 149,259 (318)

Metformin Use and Clinical Outcomes in Autosomal Dominant Polycystic Kidney Disease: A Nationwide Cohort Study. [PDF]

Biomedicines
Kuo IC, Lin MY, Tsao YH, Chiu YW, Lee JJ.   +4 more
europepmc   +1 more source

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney International, 2015
A. Chapman, O. Devuyst, K. Eckardt, R. Gansevoort, T. Harris, S. Horie, B. Kasiske, Dwight Odland, Y. Pei, R. Perrone, Y. Pirson, R. Schrier, R. Torra, V. Torres, T. Watnick, D. Wheeler   +15 more
semanticscholar   +1 more source

Identification of 3 novel mutations (Y4236X, Q3820X, 11745+2 ins3) in autosomal dominant polycystic kidney disease 1 gene (PKD1)

, 2000
Régine Perrichot, Bernard Mercier, Aurore Carré, J Clèdes, Claude Férec   +4 more
openalex   +1 more source

Autosomal dominant polycystic kidney disease

, 2013
Ayla Al Kabbani, David Cuete
openaire   +2 more sources

Advances and Challenges in Modeling Autosomal Dominant Polycystic Kidney Disease: A Focus on Kidney Organoids. [PDF]

Biomedicines
Gu J, Liu F, Li L, Mao J.
europepmc   +1 more source

Cardiac and Renal Effects of Standard Versus Rigorous Blood Pressure Control in Autosomal-Dominant Polycystic Kidney Disease [PDF]

, 2002
Robert W. Schrier, Kimberly K. McFann, Margaret Johnson, Arlene B. Chapman, Charles L. Edelstein, Godela Brosnahan, Tevfik Ecder, L. O. Tison   +7 more
openalex   +1 more source

A case report of atypical autosomal dominant polycystic kidney disease presenting as glomerulocystic kidney superimposed with thin basement membrane nephropathy. [PDF]

BMC Nephrol
Wang W, Chen L, Ding F, Li X.
europepmc   +1 more source

INFLUENCE OF THE ENDOTHELIAL NITRIC OXIDE SYNTHASE POLYMORPHISM ON THE PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE AND IgA NEPHROPATHY [PDF]

, 2002
M Merta, Jana Reiterová, Vladimı́r Tesař, Jitka Štekrová, Ondřej Viklický   +4 more
openalex   +1 more source

Renoprotective effects of combination therapy with tolvaptan and dapagliflozin in autosomal dominant polycystic kidney disease: a four-case series. [PDF]

CEN Case Rep
Nishida J, Yamakawa M, Miura S, Yasutomi M.   +3 more
europepmc   +1 more source

TRANSPLANTATION, NOT DIALYSIS, CORRECTS POST-BINEPHRECTOMY HYPERAMMONEMIA IN A PATIENT WITH AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) ASSOCIATED WITH CONGENITAL HEPATIC FIBROSIS (CHF).

, 2000
E. Renoult, Luc Frimat, P. Clavel, M. Kessler   +3 more
openalex   +1 more source